ACT Brief: AI and Wearables for Patient Monitoring, FDA Modernizes Evidence Standards, and Regulatory Alignment in Rare Disease

In today's ACT Brief, we explore how AI can parse wearable data streams to identify subtle clinical patterns, FDA's four major policy shifts modernizing drug development and approval standards, and ongoing questions about regulatory consistency in rare disease pathways.